oratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at
www.rbclifesciences.com.
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
'/>"/>SOURCE RBC Life Sciences Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Life Sciences Discovery awards health research program grants2.
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform3.
Laureate Education Names Dr. Francisco Gutierrez Senior Vice President for Medicine and Health Sciences4.
DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations5.
ZINO Societys Call for Life Sciences Entrepreneurs Seeking Funding6.
Human Genome Sciences to Sponsor Conference Call7.
Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus8.
Gene Network Sciences Announces Creation of Spin-off Entity Focused on Quantitative Finance and E-Commerce9.
BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters 10.
Growing Demand for High-Quality and Cost-Effective Imaging Equipment in Life Sciences11.
Burroughs Wellcome Fund award creates new Ph.D. path linking laboratory and population sciences